Azora Therapeutics, Inc. (AZR)
Azora Therapeutics is a biopharmaceutical company developing treatments for serious inflammatory diseases. Its lead program, AT177, is an oral, colon-targeted aryl hydrocarbon receptor agonist in development for ulcerative colitis.
Industry: Medical - Pharmaceuticals
Azora Therapeutics, Inc.
NASDAQ:AZRHealthcare · Biotechnology
PrePre-market+4.20%$3.97
Close$5.05+36.12%
Mkt Cap$13.26M
Float1.66M
O/S2.63M
Vol
$ Vol
RVOL
Inst Own-
SI10.8%
Earnings
Dilution
Financials Summary
No financial data available.
Debt & Equity
No debt & equity data available.
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
2-year cumulative
1:25
Nasdaq bars a compliance period at 1:250
- 1:25Reverse splitFeb 6, 202625 shares → 1
- 1:25Reverse splitAug 7, 202325 shares → 1
Balance Sheet Details
No balance sheet details available.
Income Statement
No income statement data available.
Balance Sheet
No balance sheet data available.
Cash Flow Statement
No cash flow data available.